🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This trial is divided into two parts, a dose-escalation study (phase 1) and...
Status
Suspended
Location
University of Alabama at Birmingham
Start Date
2013-08
Trial ID
NCT01933815
Treatments Being Tested
The main purpose of this study is to see whether addition of TPI 287 to FSR...
Status
Terminated
Location
H. Lee Moffitt Cancer Center and Research Institute
Start Date
2014-10-09
Trial ID
NCT02187822
Treatments Being Tested
The primary objective of the study is to determine the response rate to TPI...
Status
Terminated
Location
Cedars-Sinai Medical Center
Start Date
2007-01
Trial ID
NCT00479635
The goal of the Phase I portion of this study is to find the highest tolera...
Status
Terminated
Location
University of Texas MD Anderson Cancer Center
Start Date
2010-02-03
Trial ID
NCT01067066
Treatments Being Tested
The goal of this clinical research study is to learn if TPI 287 can help to...
Status
Terminated
Location
UT MD Anderson Cancer Center
Start Date
2010-04
Trial ID
NCT01113463
Treatments Being Tested
The purpose of this research study is to evaluate a new investigational dru...
Status
Completed
Location
Rady Children's Hospital
Start Date
2009-03
Trial ID
NCT00867568
Treatments Being Tested
Tapestry Pharmaceuticals, Inc. has developed a novel taxane analog, TPI 287...
Status
Completed
Location
Arizona Clinical Research Center
Start Date
2005-05
Trial ID
NCT00113724
Treatments Being Tested
The purpose of this research study is to evaluate a new investigational dru...
Status
Terminated
Location
Rady Children's Hospital
Start Date
2011-12
Trial ID
NCT01483820
Treatments Being Tested
The purpose of this study is to evaluate the safety, maximum tolerated dose...
Status
Terminated
Location
University of Alabama at Birmingham
Start Date
2014-01
Trial ID
NCT02047214
Treatments Being Tested
The primary objective of the study is to assess the activity of TPI 287 as ...
Status
Terminated
Location
Desert Hematology Oncology Medical Group, Inc.
Start Date
2007-10
Trial ID
NCT00553813
Treatments Being Tested